SBFM
REGN icon

S-Bank Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

S-Bank Fund Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$459K Sell
594
-22
-4% -$16.8K 0.07% 120
2025
Q4 		$475K Sell
616
-532
-46% -$361K 0.06% 121
2025
Q3 		$645K Sell
1,148
-15
-1% -$8.48K 0.09% 129
2025
Q2 		$611K Buy
1,163
+125
+12% +$69.8K 0.09% 134
2025
Q1 		$658K Buy
+1,038
New +$714K 0.12% 106

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

S-Bank Fund Management's REGN Position: Q1 2026 in Review

S-Bank Fund Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.6% in Q1 2026, selling an estimated $16.8K and leaving 594 shares worth $459K. The position accounts for 0.07% of the portfolio, ranked #120.

S-Bank Fund Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $658K in Q1 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • S-Bank Fund Management held 594 shares of Regeneron Pharmaceuticals worth $459K as of Q1 2026.
  • S-Bank Fund Management sold 22 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $16.8K.
  • Regeneron Pharmaceuticals made up 0.07% of S-Bank Fund Management's portfolio in Q1 2026, its #120 holding.
  • S-Bank Fund Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • S-Bank Fund Management's Regeneron Pharmaceuticals position peaked at $658K in Q1 2025.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on S-Bank Fund Management's 13F filing for Q1 2026, filed 11 May 2026.